XIDORGEX Trademark

Trademark Overview


On Wednesday, April 6, 2016, a trademark application was filed for XIDORGEX with the United States Patent and Trademark Office. The USPTO has given the XIDORGEX trademark a serial number of 86966111. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 25, 2019. This trademark is owned by Pfizer Inc.. The XIDORGEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
xidorgex

General Information


Serial Number86966111
Word MarkXIDORGEX
Filing DateWednesday, April 6, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 25, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 11, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, November 25, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 25, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, March 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 14, 2019EXTENSION 5 GRANTED
Friday, March 8, 2019EXTENSION 5 FILED
Thursday, March 14, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 8, 2019TEAS EXTENSION RECEIVED
Wednesday, October 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 1, 2018EXTENSION 4 GRANTED
Monday, October 1, 2018EXTENSION 4 FILED
Monday, October 1, 2018TEAS EXTENSION RECEIVED
Thursday, April 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 10, 2018EXTENSION 3 GRANTED
Tuesday, April 10, 2018EXTENSION 3 FILED
Tuesday, April 10, 2018TEAS EXTENSION RECEIVED
Saturday, September 30, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 28, 2017EXTENSION 2 GRANTED
Thursday, September 28, 2017EXTENSION 2 FILED
Thursday, September 28, 2017TEAS EXTENSION RECEIVED
Wednesday, March 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 13, 2017EXTENSION 1 GRANTED
Monday, March 13, 2017EXTENSION 1 FILED
Monday, March 13, 2017TEAS EXTENSION RECEIVED
Tuesday, October 25, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 30, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2016PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 22, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 19, 2016ASSIGNED TO EXAMINER
Monday, April 11, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 9, 2016NEW APPLICATION ENTERED IN TRAM